HLA class II is a factor in cardiovascular morbidity and mortality rates in patients with type 1 diabetes

Diabetologia

Volumn 55, Issue 11, 2012, Pages 2963-2969

  Soderlund J ^a,b   Forsblom, C ^a,b   Ilonen, J ^c,d   Thorn, L M ^a,b   Waden J ^a,b   Parkkonen, M ^a,b   Groop, P H ^a,b,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cardiovascular disease; Human leucocyte antigen; Mortality; Type 1 diabetes

Indexed keywords

ALBUMIN; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; INSULIN;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; FINNISH; FOLLOW UP; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FINLAND; FOLLOW-UP STUDIES; HAPLOTYPES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; RISK FACTORS;

EID: 84867583258     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2670-6     Document Type: Article

References (24)

1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H (2001) Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 44(Suppl 2):S14-S21
2. Groop PH, Thomas MC, Moran JL et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651-1658
3. Hansson GK, Libby P, Schonbeck U, Yan ZQ (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91:281-291
4. Hansson GK, Robertson AK, Soderberg-Naucler C (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1:297-329
5. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
6. Barrett JC, Clayton DG, Concannon P et al (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703-707
7. Hermann R, Turpeinen H, Laine AP et al (2003) HLA DR-DQencoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families. Tissue Antigens 62:162-169
8. Palikhe A, Sinisalo J, Seppanen M, Valtonen V, Nieminen MS, Lokki ML (2007) Human MHC region harbors both susceptibility and protective haplotypes for coronary artery disease. Tissue Antigens 69:47-55
9. Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: Association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019-2024
10. Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149-150
11. Bjorkbacka H, Lavant EH, Fredrikson GN et al (2010) Weak associations between human leucocyte antigen genotype and acute myocardial infarction. J Intern Med 268:50-58
12. Sun W, Cui Y, Zhen L, Huang L (2011) Association between HLA-DRB1, HLA-DRQB1 alleles, and CD4(+)CD28(null) T cells in a Chinese population with coronary heart disease. Mol Biol Rep 38:1675-1679
13. Farragher TM, Goodson NJ, Naseem H et al (2008) Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis. Arthritis Rheum 58:359-369
14. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ et al (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125-132
15. Mattey DL, Thomson W, Ollier WE et al (2007) Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: Results of eighteen years of follow up from the early rheumatoid arthritis study. Arthritis Rheum 56:1408-1416
16. Paakkanen R, Lokki ML, Seppanen M, Tierala I, Nieminen MS, Sinisalo J (2012) Proinflammatory HLA-DRB1*01-haplotype predisposes to ST-elevation myocardial infarction. Atherosclerosis 221:461-466
17. Boger CA, Stubanus M, Haak T et al (2007) Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with endstage diabetic nephropathy. Nephrol Dial Transplant 22:154-162
18. Turesson C (2004) Endothelial expression of MHC class II molecules in autoimmune disease. Curr Pharm Des 10:129-143
19. Sitia S, Tomasoni L, Atzeni F et al (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9:830-834
20. Yla-Herttuala S, Palinski W, Butler SW, Picard S, Steinberg D, Witztum JL (1994) Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler Thromb 14:32-40
21. Burut DF, Karim Y, Ferns GA (2010) The role of immune complexes in atherogenesis. Angiology 61:679-689
22. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12:204-212
23. Davies RW, Wells GA, Stewart AF et al (2012) A genome wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex. Circ Cardiovasc Genet 5:217-225
24. Liu B, Xiong L, Tian C et al (2012) HLA-DRB1*12:02:01 plays a protective role against coronary artery disease in women of southern Han Chinese descent. Hum Immunol 73:122-126